| Literature DB >> 26415087 |
Zi-Zhen Xu1,2, Wan-Bin Fu2, Zhen Jin2, Pei Guo2, Wen-Fang Wang2, Jun-Min Li1.
Abstract
This study investigated the cytotoxic effect of oridonin (ORI), a diterpenoid isolated from Rabdosia rubescens, in human diffuse large B cell lymphoma (DLBCL) in vitro and in vivo and the potential molecular mechanisms for ORI-induced cell apoptosis. ORI treatment caused reactive oxygen species (ROS)-mediated oxidative DNA damage response (DDR) and the c-Jun N-terminal kinase (JNK) pathway activation, leading to an induction of intrinsic apoptosis. ROS abolition blocked ORI-induced apoptosis and attenuated the expression of phospho-histone H2AX and phospho-JNK, indicating that ROS-mediated DNA damage and JNK pathway activation were involved in ORI-induced apoptosis. The systemic administration of ORI suppressed the growth of human DLBCL xenografts without showing significant toxicity. These findings suggest that ORI may have promising therapeutic application in DLBCL.Entities:
Keywords: Apoptosis; DNA damage response; JNK; diffuse large B cell lymphoma; oridonin; reactive oxygen species
Mesh:
Substances:
Year: 2015 PMID: 26415087 DOI: 10.3109/10428194.2015.1061127
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022